Search clinical trials for: K5-101

Total 4174 results

Siemens Molecular Imaging

Terminated

[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Carotid Stenosis

United States
Balaji Tamarappoo

Completed

TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study (K5-C200)

Carotid Arteries

United States
Siemens Molecular Imaging

Completed

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug (K5-101)

Non-squamous Non-small Cell Lung Cancer | Metastatic Breast Cancer | Metastatic Colon/Rectum Cancer

United States
Siemens Molecular Imaging

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 (K5)

Melanoma | Sarcoma | Breast Cancer | Lung Cancer | High Grade Gliomas

United States
Kırıkkale University

Recruiting

The Effect of the Diaphragm in Urinary Incontinence

Urinary Incontinence

Turkey
Centre Francois Baclesse

Completed

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy (TERMATEP)

Metastasis | Non-seminomatous Germ Cell Tumors

France
Baylor Research Institute

Recruiting

COSMED K5 Validation and Reliability Study (K5)

Exercise | Cardiopulmonary

United States
Centre Henri Becquerel

Unknown

Study of the Angiogenesis by PET/CT in Patients With Lymphoma (RGDLymphome)

Lymphoma

France
Therapeutics: 101 Inc.

No longer available

Use of the Pressure Right Device After Laparoscopic Surgery

Nausea | Vomiting
101 Therapeutics

Active, not recruiting

101-PGC-005 for the Treatment of COVID-19

COVID-19

India
101 Therapeutics

Terminated

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

COVID-19

Israel
101 Therapeutics

Active, not recruiting

Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects

Virus Diseases | COVID-19 | Infectious Disease | Glucocorticoids Toxicity

India
Universitair Ziekenhuis Brussel

Completed

HCG Versus Spontaneous LH in Intrauterine Insemination (IUI ) Cycles

Spontaneous Triggering of Ovulation vs. Administration of Human Chorionic Gonadotropin in Patients Undergoing IUI

Belgium
The Cleveland Clinic

Terminated

TRACER RGD-K5 Carotid Plaque Imaging Study (TRACER)

Carotid Stenosis | Carotid Artery Disease

United States
Universitair Ziekenhuis Brussel

Completed

Low Dose hCG in the Late Follicular Phase

Infertility

Belgium
Universitair Ziekenhuis Brussel

Completed

Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium

Infertility

Belgium
Peplin

Completed

Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

Actinic Keratoses

Australia
Chang Gung Memorial Hospital

Unknown

RGD-K5 in Head and Neck Cancer Patients

Head and Neck Neoplasms
University of California, Los Angeles
Great Ormond Street Hospital for Children NHS Foundation Trust

Enrolling by invitation

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID

Adenosine Deaminase Deficiency | Severe Combined Immunodeficiency (SCID)

United States, United Kingdom
Kures, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults

Acute Pain

New Zealand
Asahi Kasei Pharma Corporation
Emergent Clinical Consulting, LLC

Terminated

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) (ENHANCE)

Spinal Stenosis | Degenerative Spondylolisthesis

Canada
Oncorus, Inc.
Merck Sharp & Dohme LLC

Terminated

Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors

Melanoma | Cancer | Breast Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Advanced Solid Tumor | Liver Metastases | Colorectal Carcinoma | Non-melanoma Skin Cancer

United States, Canada
TR Therapeutics

Completed

Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation

Wounds

United States
Panbela Therapeutics, Inc.

Recruiting

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer (ASPIRE)

Pancreatic Cancer Metastatic | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV

United States, Belgium, Germany, Spain, Korea, Republic of, Australia, France, Italy, Austria, United Kingdom
Transposon Therapeutics, Inc.

Active, not recruiting

A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy

United States
University of Florida
Novatek

Not yet recruiting

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Hepatocellular Carcinoma
Abalonex, LLC

Not yet recruiting

Safety and Efficacy of ABX-101 in Participants Aged 18 to 50 Years of Age With Moderate to Severe Traumatic Brain Injury

Traumatic Brain Injury | Cerebral Edema
Benjamin Izar

Terminated

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma (ATX-101)

Leiomyosarcoma | Liposarcoma

United States
Memorial Sloan Kettering Cancer Center
Fordham University

Active, not recruiting

Identifying and Measuring Depression in Older Cancer Patients

Older Cancer Patients

United States
Idera Pharmaceuticals, Inc.

Completed

A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors (ILLUMINATE-101)

Melanoma | Refractory Solid Tumors

United States, Israel
Alaunos Therapeutics

Completed

A Phase I Trial of ZIO-101 in Solid Tumors

Solid Tumors

United States
Brigham and Women's Hospital

Recruiting

CP101 for the Treatment of Ulcerative Colitis

Ulcerative Colitis

United States
Axovant Sciences Ltd.

Completed

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Dementia With Lewy Bodies

United States, Canada, France, Italy, Netherlands, Spain, United Kingdom
Alaunos Therapeutics

Unknown

Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Advanced Cancer

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety and Bioavailability of IV and SC LBR-101

Bioavailability and Pharmacokinetics

United States
Ralexar Therapeutics, Inc.

Completed

A Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis | Eczema, Atopic

United States
Axovant Sciences Ltd.

Terminated

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

Dementia With Lewy Bodies

United States, Canada, France, Italy, Netherlands, Spain, United Kingdom
Alaunos Therapeutics

Completed

Study of ZIO-101 in Multiple Myeloma

Multiple Myeloma

United States, Canada
Alaunos Therapeutics

Completed

A Phase I Trial of ZIO-101 in Hematologic Cancers

Lymphoma | Multiple Myeloma | Acute Leukemia | Chronic Myeloproliferative Disease | Chronic Lymphoproliferative Disease | Poor-risk Myelodysplasia (MDS)

United States
Scioderm, Inc.
Amicus Therapeutics

Completed

Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa

Epidermolysis Bullosa

United States
Ralexar Therapeutics, Inc.

Unknown

Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States, Canada
Aclaris Therapeutics, Inc.

Completed

Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis (SK)

United States
Healthpoint

Withdrawn

HP011-101, HP828-101, and Standard Care for Pressure Ulcers

Pressure Ulcers
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer (FLUOCAR-1)

Peritoneal Carcinomatosis

France
Transposon Therapeutics, Inc.

Recruiting

TPN-101 in Aicardi-Goutières Syndrome (AGS)

Aicardi-Goutières Syndrome (AGS)

United Kingdom, France, Italy
Flame Biosciences

Completed

A Bioavailability Study of FL-101 in Healthy Male and Female Subjects

Healthy Subjects

United States
Lantheus Medical Imaging

Completed

A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure

Heart Failure

United States
Perception Neuroscience
Precision For Medicine; IQVIA Biotech

Completed

A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD

Treatment Resistant Depression

United States, Germany, Poland
Desentum Oy

Completed

Study to Evaluate Safety and Tolerability of sc Immunotherapy With DM-101 in Adults With Birch Pollen Allergy

Birch Pollen Allergy

Finland
Azure Biotech Inc.

Not yet recruiting

Open-Label Study of Vaginal AZU-101 in Postmenopausal Women

Postmenopausal Symptoms

Search clinical trials for: K5-101

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations